Scout | FDA funding for studies on ALS and other rare neurodegenerative diseases

forecast

FDA funding for studies on ALS and other rare neurodegenerative diseases

This FDA funding opportunity supports research studies aimed at advancing the development of medical interventions for ALS and other rare neurodegenerative diseases in both adults and children. The goal is to fill key knowledge gaps and generate evidence that can help prevent, diagnose, mitigate, treat, or cure these conditions. Supported studies are intended to inform current and future produ…

Source

Agency: Food and Drug Administration

Eligibility

government

industry:research

nonprofit

small_business

tribal

university

For profit organizations other than small businesses

Native American tribal governments (Federally recognized)

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Private institutions of higher education

State governments

Keywords

als research

rare neurodegeneration

medical product development

fda funding

disease intervention

clinical studies

biomedical research

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers